0G8X

Immunovia Ab (publ)
191.40
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Immunovia Ab (publ) 0G8X London Ordinary Share
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 191.40 19:00:00
Open Price Low Price High Price Close Price Prev Close
191.40 191.40
more quote information »

Recent News

Date Time Source Heading
1/19/202308:20PRNUSImmunovia announces updated financial calendar for financial..
1/19/202308:16PRNUSImmunovia announces updated financial calendar for financial..
1/19/202302:50PRNUSImmunovia realigning Swedish operations with strategic..
1/19/202302:48PRNUSImmunovia realigning Swedish operations with strategic..
1/17/202303:06PRNUSImmunovia Appoints Lara E. Sucheston-Campbell as Head of..
1/17/202303:04PRNUSImmunovia Appoints Lara E. Sucheston-Campbell as Head of..
12/05/202202:54PRNUSImmunovia strengthens US organization to continue..
12/05/202202:52PRNUSImmunovia strengthens US organization to continue..
11/30/202203:09PRNUSCenters for Medicare & Medicaid Services finalizes its..
11/30/202203:07PRNUSCenters for Medicare & Medicaid Services finalizes its..
11/16/202202:47PRNUSChief Executive Offier, Philipp Mathieu, buys Immunovia..
11/16/202202:46PRNUSChief Executive Offier, Philipp Mathieu, buys Immunovia..
11/11/202211:58PRNUSImmunovia announces the financial calendar for financial..
11/11/202211:56PRNUSImmunovia announces the financial calendar for financial..
11/10/202202:57PRNUSImmunovia Publishes Interim Report Jan-Sep 2022
11/10/202202:56PRNUSImmunovia Publishes Interim Report Jan-Sep 2022
11/03/202209:25PRNUSInvitation to Immunovia's Q3 presentation
11/03/202209:24PRNUSInvitation to Immunovia's Q3 presentation
10/20/202203:15PRNUSNomination Committee appointed for the 2023 Annual General..
10/20/202203:13PRNUSNomination Committee appointed for the 2023 Annual General..
10/19/202203:05PRNUSImmunovia announces executive management team changes to..
10/19/202203:03PRNUSImmunovia announces executive management team changes to..
10/17/202202:47PRNUSImmunovia launches a strategic partnership with Proteomedix..
10/17/202202:44PRNUSImmunovia launches a strategic partnership with Proteomedix..
10/12/202202:41PRNUSImmunovia announces positive update on physician experience..
10/12/202202:39PRNUSImmunovia announces positive update on physician experience..
9/26/202203:05PRNUSCenters for Medicare & Medicaid Services issues preliminary..
9/26/202203:03PRNUSCenters for Medicare & Medicaid Services issues preliminary..
8/24/202202:47PRNUSImmunovia Publishes Interim Report Jan-June 2022
8/24/202202:45PRNUSImmunovia Publishes Interim Report Jan-June 2022
8/23/202202:52PRNUSImmunovia to present at Gilmartin Group's Emerging Growth..
8/23/202202:49PRNUSImmunovia to present at Gilmartin Group's Emerging Growth..
8/22/202207:41PRNUSInvitation to Immunovia's Q2 presentation
8/22/202207:40PRNUSInvitation to Immunovia's Q2 presentation
8/11/202204:53PRNUSImmunovia, Inc. Issued Clinical and Public Health Laboratory..
8/11/202204:49PRNUSImmunovia, Inc. Issued Clinical and Public Health Laboratory..
7/05/202203:47PRNUSImmunovia: CPT PLA Code for the IMMray™ PanCan-d test..
7/05/202203:45PRNUSImmunovia: CPT PLA Code for the IMMray™ PanCan-d test..
6/30/202203:31PRNUSThe PanDIA-1 study, for early detection of pancreatic cancer..
6/30/202203:24PRNUSThe PanDIA-1 study, for early detection of pancreatic cancer..
6/27/202203:25PRNUSInvitation to Immunovia's Presentation of PanFAM-1 Results
6/27/202203:19PRNUSInvitation to Immunovia's Presentation of PanFAM-1 Results
6/27/202203:07PRNUSPanFAM-1 Results Partly Inconclusive
6/27/202202:55PRNUSPanFAM-1 Results Partly Inconclusive
6/02/202202:47PRNUSPhilipp Mathieu appointed CEO of Immunovia AB
6/02/202202:46PRNUSPhilipp Mathieu appointed CEO of Immunovia AB
5/23/202203:01PRNUSImmunovia, Inc. market access increases when achieving..
5/23/202202:57PRNUSImmunovia, Inc. market access increases when achieving..
5/17/202202:48PRNUSImmunovia, Inc. achieves Clinical Laboratory Licensure from..
5/17/202202:46PRNUSImmunovia, Inc. achieves Clinical Laboratory Licensure from..